Search
Close this search box.
Search
Close this search box.

Within3 in PharmExec.com

diversity in life science

Within3’s Meerim Almazbek makes the case for developing a diversity mindset in the pharmaceutical industry to improve everything from insight gathering to trial design.

Industry survey says virtual and hybrid engagements are here to stay

virtual engagement survey results

Virtual engagement survey results show medical affairs, clinical/R&D, and commercial life science teams will likely continue conducting virtual or hybrid events. Most survey respondents in the life science industry believe teams are likely to continue conducting virtual or hybrid engagements as travel resumes in the wake of increasing vaccination rates. Specifically, 72% for medical affairs, […]

Within3 in Mexico Business News

Miriam Bello with Mexico Business News interviewed Within3 CEO Lance Hill about how virtual engagement technology benefits life science organizations.

Within3 Announces Acquisition of rMark Bio™

Within3 announced today the acquisition of rMark Bio, allowing for deeper access to and more efficient delivery of KOL and stakeholder insights to life science companies worldwide.

Within3 in Cleveland Business Journal

Within3 CEO Lance Hill talks about business growth during a pandemic, the company’s role in industry discussions around COVID-19, and what keeps him up at night.

Within3 in MedCityNews

While Covid-19 temporarily paused our ability to interact face-to-face, it also ushered in an era of global collaboration and the ability for life science teams to make decisions based on an expanded viewpoint.